Rhythm Pharmaceuticals, Inc. RYTM Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 89.4%-0.2pp | 89.7%0.0pp | 89.4%+0.8pp | 89.2%+0.4pp | 89.6%+1.2pp | |
| Operating margin | -90.9%+35.2pp | -101.2%+103pp | -106.8%+129pp | -113.5%+147pp | -126.1%+169pp | |
| Net margin | -93.3%+29.9pp | -103.6%+96.7pp | -110.3%+120pp | -117.1%+138pp | -123.3%+175pp | |
| Returns | ||||||
| Return on assets | -48.9%+3.4pp | -45.1%+26.8pp | -44.2%+28.0pp | -48.5%+26.5pp | -52.3%+38.4pp | |
| Efficiency | ||||||
| Asset turnover | 0.5×+0.1× | 0.4×+0.1× | 0.4×+0.1× | 0.4×+0.1× | 0.4×+0.1× | |
| Inventory turnover | 1×-0.1× | 0.9×-0.1× | 1×-0.2× | 1.1×— | 1×— | |
| Liquidity | ||||||
| Current ratio | 4.2×+0.9× | 4.4×+1.2× | 4.7×+1.3× | 2.8×-3.7× | 3.3×-1.1× | |
| Quick ratio | 3.9×+0.8× | 4.2×+1.1× | 4.5×+1.2× | 2.6×-3.7× | 3.1×-1.1× | |
| Cash ratio | 0.6×-0.3× | 0.5×-0.3× | 0.5×0.0× | 1×-1.9× | 0.9×0.0× | |
| Leverage | ||||||
| Debt-to-assets | 0.3×0.0× | 0.2×-0.1× | 0.2×+0.2× | 0.3×+0.3× | 0.3×+0.3× | |
| Interest coverage | -10×-1.7× | -9.3×+3.9× | -8.7×+5.2× | -8.1×+7.5× | -8.3×+8.9× | |
| Per Share | ||||||
| Book value per share | $1.81+502% | $2.14+501% | $2.25+1,126% | -$0.19-129% | $0.30-70.7% | |
| Valuation | ||||||
| Market capitalization | $5.94B+77.3% | $7.14B+108% | $6.71B+110% | $4.05B+64.0% | $3.35B+28.5% | |
| Enterprise value | $5.99B+78.4% | $7.2B+108% | $6.77B+115% | $4.03B+74.2% | $3.36B+31.4% | |
| Price / sales | 27.3×+2.9× | 37.6×+11.2× | 38.5×+10.1× | 25.9×+1.7× | 24.5×-3.9× | |
| EV / sales | 27.6×+3.1× | 38×+11.3× | 38.8×+10.8× | 25.8×+3.1× | 24.5×-3.3× | |
| Earnings yield | -3.4%+1.6pp | -2.8%+4.8pp | -2.9%+5.2pp | -4.5%+6.0pp | -5%+5.5pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Rhythm Pharmaceuticals, Inc.'s profit margins?
- Rhythm Pharmaceuticals, Inc. (RYTM) runs a 89.4% gross margin and a -90.9% operating margin, with a -93.3% net margin.
- Where do Rhythm Pharmaceuticals, Inc.'s ratios come from?
- Every ratio is computed from Rhythm Pharmaceuticals, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
